<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37587233</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-160X</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Rheumatology international</Title><ISOAbbreviation>Rheumatol Int</ISOAbbreviation></Journal><ArticleTitle>Myocarditis in connective tissue diseases: an often-overlooked clinical manifestation.</ArticleTitle><Pagination><StartPage>1983</StartPage><EndPage>1992</EndPage><MedlinePgn>1983-1992</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00296-023-05428-w</ELocationID><Abstract><AbstractText>To discuss what is currently known about myocarditis in the context of major connective tissue diseases, including Systemic lupus erythematosus, Rheumatoid Arthritis, Sjogren, Dermato-myositis and Polymyositis, Systemic Sclerosis, and Mixed connective tissue disease. Variability exists between studies regarding the incidence of myocarditis in connective tissue diseases, which is hypothesized to be the result of its subclinical course in most cases. Extensive gaps of knowledge exist in the field of pathophysiology. Although endomyocardial biopsy remains to be the gold standard for diagnosis, the advancement in non-invasive modalities such as cardiac MRI, echocardiography, and nuclear medicine has allowed for earlier and more frequent detection of myocarditis. A lack of treatment guidelines was found across the different connective tissue diseases. Most of the literature available revolved around myocarditis in the context of Systemic lupus erythematosus. Numerous recent studies were published that contributed to advancements in diagnosis and treatment however, there remains a lack of diagnostic and treatment guidelines.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Azzam</LastName><ForeName>Muayad</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2046-8343</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, The University of Jordan, Amman, 11942, Jordan. Azzam.muayad@outlook.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Awad</LastName><ForeName>Amro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0821-4279</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, The University of Jordan, Amman, 11942, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abugharbyeh</LastName><ForeName>Aya</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0009-5791-1378</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology and Immunology, University of Toledo Medical Center, Toledo, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahaleh</LastName><ForeName>Bashar</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-4666-0250</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology and Immunology, University of Toledo Medical Center, Toledo, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Rheumatol Int</MedlineTA><NlmUniqueID>8206885</NlmUniqueID><ISSNLinking>0172-8172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003240" MajorTopicYN="Y">Connective Tissue Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017285" MajorTopicYN="Y">Polymyositis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008947" MajorTopicYN="Y">Mixed Connective Tissue Disease</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arthritis</Keyword><Keyword MajorTopicYN="N">Cardiac involvement</Keyword><Keyword MajorTopicYN="N">Connective tissue diseases</Keyword><Keyword MajorTopicYN="N">Myocarditis</Keyword><Keyword MajorTopicYN="N">Myositis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>16</Day><Hour>23</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37587233</ArticleId><ArticleId IdType="doi">10.1007/s00296-023-05428-w</ArticleId><ArticleId IdType="pii">10.1007/s00296-023-05428-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pepmueller PH (2006) Undifferentiated connective tissue disease, mixed connective tissue disease, and overlap syndromes in rheumatology. Mo Med 113:136&#x2013;140</Citation></Reference><Reference><Citation>Stougiannos PN, Mytas DZ, Katsaros AA, Kakkavas AT, Androulakis AE, Kallikazaros IE, Chrissos DN (2009) Chest pain and ST-segment elevation in a patient with polymyositis: a case report. Cases J 2:84</Citation><ArticleIdList><ArticleId IdType="pubmed">19166609</ArticleId><ArticleId IdType="pmc">2639563</ArticleId><ArticleId IdType="doi">10.1186/1757-1626-2-84</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose NR (2016) Viral myocarditis. Curr Opin Rheumatol 2016(28):383&#x2013;389</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000303</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose NR, Neumann DA, Herskowitz A (1992) Coxsackievirus myocarditis. Adv Intern Med 37:411&#x2013;429</Citation><ArticleIdList><ArticleId IdType="pubmed">1558005</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A, Shiau J, Guyatt G (1998) The ineffectiveness of immunosuppressive therapy in lymphocytic myocarditis: an overview. Ann Intern Med 129:317&#x2013;322</Citation><ArticleIdList><ArticleId IdType="pubmed">9729186</ArticleId><ArticleId IdType="doi">10.7326/0003-4819-129-4-199808150-00009</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose NR (2009) Myocarditis: infection versus autoimmunity. J Clin Immunol 29:730&#x2013;737</Citation><ArticleIdList><ArticleId IdType="pubmed">19826933</ArticleId><ArticleId IdType="doi">10.1007/s10875-009-9339-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heli&#xf6; T, Heymans S, Jahns R et al (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34:2636&#x2013;2648, 2648a&#x2013;2648d</Citation><ArticleIdList><ArticleId IdType="pubmed">23824828</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/eht210</ArticleId></ArticleIdList></Reference><Reference><Citation>Villablanca P, Mohananey D, Meier G, Yap JE, Chouksey S, Abegunde AT (2015) Salmonella berta myocarditis: case report and systematic review of non-typhoid salmonella myocarditis. World J Cardiol 7:931&#x2013;937</Citation><ArticleIdList><ArticleId IdType="pubmed">26730299</ArticleId><ArticleId IdType="pmc">4691820</ArticleId><ArticleId IdType="doi">10.4330/wjc.v7.i12.931</ArticleId></ArticleIdList></Reference><Reference><Citation>Childs L, Gupta S (2012) Salmonella enteritidis induced myocarditis in a 16-year-old girl. BMJ Case Rep. https://doi.org/10.1136/bcr-2012-007628</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2012-007628</ArticleId><ArticleId IdType="pubmed">23188875</ArticleId><ArticleId IdType="pmc">4545010</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Diem L, Arnold K (1974) Typhoid fever with myocarditis. Am J Trop Med Hyg 23:218&#x2013;221</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1974.23.218</ArticleId></ArticleIdList></Reference><Reference><Citation>Hidron A, Vogenthaler N, Santos-Preciado JI, Rodriguez-Morales AJ, Franco-Paredes C, Rassi AJ (2010) Cardiac involvement with parasitic infections. Clin Microbiol Rev 23:324&#x2013;349</Citation><ArticleIdList><ArticleId IdType="pubmed">20375355</ArticleId><ArticleId IdType="pmc">2863361</ArticleId><ArticleId IdType="doi">10.1128/CMR.00054-09</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey S, Rajasurya V (2023) Nonviral myocarditis. StatPearls Publishing, Treasure Island</Citation></Reference><Reference><Citation>Mavrogeni SI, Kitas GD, Dimitroulas T, Sfikakis PP, Seo P, Gabriel S, Patel AR, Gargani L, Bombardieri S, Matucci-Cerinic M et al (2016) Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use. Int J Cardiol 217:135&#x2013;148</Citation><ArticleIdList><ArticleId IdType="pubmed">27179903</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2016.04.158</ArticleId></ArticleIdList></Reference><Reference><Citation>Podlesnikar T, Lapinskas T (2019) Cardiac involvement in connective tissue disorders: terra incognita. JACC Case Rep 1:243&#x2013;245</Citation><ArticleIdList><ArticleId IdType="pubmed">34316797</ArticleId><ArticleId IdType="pmc">8301536</ArticleId><ArticleId IdType="doi">10.1016/j.jaccas.2019.07.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Oziera&#x144;ski K, Tymi&#x144;ska A, Kobylecka M, Caforio ALP, &#x160;obi&#x107;-&#x160;aranovi&#x107; D, Risti&#x107; AD, Maksimovi&#x107; R, Seferovi&#x107; PM, Marcolongo R, Kr&#xf3;licki L et al (2021) Positron emission tomography in clinically suspected myocarditis&#x2014;STREAM study design. Int J Cardiol 332:113&#x2013;118</Citation><ArticleIdList><ArticleId IdType="pubmed">33657398</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2021.02.068</ArticleId></ArticleIdList></Reference><Reference><Citation>Justiz Vaillant AA, Goyal A, Varacallo M (2022) Systemic lupus erythematosus. StatPearls Publishing, Treasure Island</Citation></Reference><Reference><Citation>Jain D, Halushka MK (2009) Cardiac pathology of systemic lupus erythematosus. J Clin Pathol 62:584&#x2013;592</Citation><ArticleIdList><ArticleId IdType="pubmed">19561227</ArticleId><ArticleId IdType="doi">10.1136/jcp.2009.064311</ArticleId></ArticleIdList></Reference><Reference><Citation>Badui E, Garcia-Rubi D, Robles E, Jimenez J, Juan L, Deleze M, Diaz A, Mintz G (1985) Cardiovascular manifestations in systemic lupus erythematosus. prospective study of 100 patients. Angiology 36:431&#x2013;441</Citation><ArticleIdList><ArticleId IdType="pubmed">4025948</ArticleId><ArticleId IdType="doi">10.1177/000331978503600705</ArticleId></ArticleIdList></Reference><Reference><Citation>Tincani A, Rebaioli CB, Taglietti M, Shoenfeld Y (2006) Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology (Oxford) 45:iv8&#x2013;iv13</Citation><ArticleIdList><ArticleId IdType="pubmed">16980725</ArticleId><ArticleId IdType="doi">10.1093/rheumatology/kel308</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng C-Y, Baritussio A, Giordani AS, Iliceto S, Marcolongo R, Caforio ALP (2022) Myocarditis in systemic immune-mediated diseases: prevalence, characteristics and prognosis. A systematic review. Autoimmun Rev 21:103037</Citation><ArticleIdList><ArticleId IdType="pubmed">34995763</ArticleId><ArticleId IdType="doi">10.1016/j.autrev.2022.103037</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH (1954) Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 33:291&#x2013;437</Citation><ArticleIdList><ArticleId IdType="pubmed">13223169</ArticleId><ArticleId IdType="doi">10.1097/00005792-195412000-00001</ArticleId></ArticleIdList></Reference><Reference><Citation>Estes D, Christian CL (1971) The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 50:85&#x2013;95</Citation><ArticleIdList><ArticleId IdType="pubmed">4109481</ArticleId><ArticleId IdType="doi">10.1097/00005792-197103000-00001</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT (2021) Update &#x3bf;n the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis 80:14&#x2013;25</Citation><ArticleIdList><ArticleId IdType="pubmed">33051219</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2020-218272</ArticleId></ArticleIdList></Reference><Reference><Citation>Winau L, HinojarBaydes R, Braner A, Drott U, Burkhardt H, Sangle S, D&#x2019;Cruz DP, Carr-White G, Marber M, Schnoes K et al (2018) High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus. Ann Rheum Dis 77:1590&#x2013;1598</Citation><ArticleIdList><ArticleId IdType="pubmed">30077990</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2018-213661</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkard T, Trendelenburg M, Daikeler T, Hess C, Bremerich J, Haaf P, Buser P, Zellweger MJ (2018) The heart in systemic lupus erythematosus&#x2014;a comprehensive approach by cardiovascular magnetic resonance tomography. PLoS&#xa0;One 13:e0202105</Citation><ArticleIdList><ArticleId IdType="pubmed">30273933</ArticleId><ArticleId IdType="pmc">6167090</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0202105</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulkley BH, Roberts WC (1975) The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am J Med 58:243&#x2013;264</Citation><ArticleIdList><ArticleId IdType="pubmed">1115070</ArticleId><ArticleId IdType="doi">10.1016/0002-9343(75)90575-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidani AK, Roberts JL, Schwartz MM, Lewis EJ (1980) Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 69:849&#x2013;858</Citation><ArticleIdList><ArticleId IdType="pubmed">7004181</ArticleId><ArticleId IdType="doi">10.1016/S0002-9343(80)80010-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Das SK, Cassidy JT (1975) Antiheart antibodies in patients with systemic lupus erythematosus. Am J Med Sci 265:275&#x2013;280</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000441-197304000-00002</ArticleId></ArticleIdList></Reference><Reference><Citation>Lash AD, Wittman AL, Quismorio FPJ (1986) Myocarditis in mixed connective tissue disease: clinical and pathologic study of three cases and review of the literature. Semin Arthritis Rheum 15:288&#x2013;296</Citation><ArticleIdList><ArticleId IdType="pubmed">2940685</ArticleId><ArticleId IdType="doi">10.1016/0049-0172(86)90024-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Logar D, Kveder T, Rozman B, Dobovisek J (1990) Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus. Ann Rheum Dis 49:627&#x2013;629</Citation><ArticleIdList><ArticleId IdType="pubmed">2396870</ArticleId><ArticleId IdType="pmc">1004179</ArticleId><ArticleId IdType="doi">10.1136/ard.49.8.627</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanwani J, Tselios K, Gladman DD, Su J, Urowitz MB (2018) Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies. Lupus 27:1296&#x2013;1302</Citation><ArticleIdList><ArticleId IdType="pubmed">29642752</ArticleId><ArticleId IdType="doi">10.1177/0961203318770018</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas G, Cohen Aubart F, Chiche L, Haroche J, Hi&#xe9; M, Hervier B, Costedoat-Chalumeau N, Mazodier K, Ebbo M, Cluzel P et al (2017) Lupus myocarditis: initial presentation and longterm outcomes in a multicentric series of 29 patients. J Rheumatol 44:24&#x2013;32</Citation><ArticleIdList><ArticleId IdType="pubmed">28042125</ArticleId><ArticleId IdType="doi">10.3899/jrheum.160493</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Toit R, Herbst PG, van Rensburg A, du Plessis LM, Reuter H, Doubell AF (2017) Clinical features and outcome of lupus myocarditis in the Western Cape, South Africa. Lupus 26:38&#x2013;47</Citation><ArticleIdList><ArticleId IdType="pubmed">27225211</ArticleId><ArticleId IdType="doi">10.1177/0961203316651741</ArticleId></ArticleIdList></Reference><Reference><Citation>Zawadowski GM, Klarich KW, Moder KG, Edwards WD, Cooper LTJ (2012) A contemporary case series of lupus myocarditis. Lupus 21:1378&#x2013;1384</Citation><ArticleIdList><ArticleId IdType="pubmed">22892209</ArticleId><ArticleId IdType="doi">10.1177/0961203312456752</ArticleId></ArticleIdList></Reference><Reference><Citation>Law WG, Thong BY, Lian TY, Kong KO, Chng HH (2005) Acute lupus myocarditis: clinical features and outcome of an oriental case series. Lupus 14:827&#x2013;831</Citation><ArticleIdList><ArticleId IdType="pubmed">16302678</ArticleId><ArticleId IdType="doi">10.1191/0961203305lu2228oa</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansari A, Larson PH (1985) Heart disease in systemic lupus erythematosus: diagnosis and management. Texas Hear Inst J 12:9&#x2013;21</Citation></Reference><Reference><Citation>Manautou L, Jerjes-Sanchez C, Meraz M, Perez-Garcia LF, Diaz-Cid A, de la Pe&#xf1;a-Almaguer E, Avila C, Sanchez L (2014) Myopericarditis with predominantly right ventricular involvement with normal B-type natriuretic peptide and cardiac tamponade as the initial manifestation of systemic lupus erythematosus. Lupus 23:935&#x2013;938</Citation><ArticleIdList><ArticleId IdType="pubmed">24704777</ArticleId><ArticleId IdType="doi">10.1177/0961203314530486</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Zhu Y-L, Li M-T, Gao N, You X, Wu Q-J, Su J-M, Shen M, Zhao L-D, Liu J-J et al (2015) Lupus myocarditis: a case&#x2013;control study from China. Chin Med J (Engl) 128:2588&#x2013;2594</Citation><ArticleIdList><ArticleId IdType="pubmed">26415795</ArticleId><ArticleId IdType="doi">10.4103/0366-6999.166029</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung J-W, Joe D-Y, Park H-J, Kim H-A, Park H-S, Suh C-H (2008) Clinical characteristics of lupus myocarditis in Korea. Rheumatol Int 28:275&#x2013;280</Citation><ArticleIdList><ArticleId IdType="pubmed">17634899</ArticleId><ArticleId IdType="doi">10.1007/s00296-007-0414-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto A, Torres S, Pissarra D, Vasconcelos G (2021) Myocardial rupture and systemic lupus erythematosus: a case report. Eur Heart J Case Rep 5:ytaa458</Citation><ArticleIdList><ArticleId IdType="pubmed">33554016</ArticleId><ArticleId IdType="doi">10.1093/ehjcr/ytaa458</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavrogeni S, Dimitroulas T, Kitas GD (2012) Multimodality imaging and the emerging role of cardiac magnetic resonance in autoimmune myocarditis. Autoimmun Rev 12:305&#x2013;312</Citation><ArticleIdList><ArticleId IdType="pubmed">22617620</ArticleId><ArticleId IdType="doi">10.1016/j.autrev.2012.05.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Alchammas J, Al-Faham Z, Roumayah Y, Wong OCY (2016) The evaluation of lupus myocarditis with 13N-ammonia and 18F-FDG PET. J Nucl Med Technol 44:210&#x2013;211</Citation><ArticleIdList><ArticleId IdType="pubmed">26769599</ArticleId><ArticleId IdType="doi">10.2967/jnmt.115.165639</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijetunga M, Rockson S (2002) Myocarditis in systemic lupus erythematosus. Am J Med 113:419&#x2013;423</Citation><ArticleIdList><ArticleId IdType="pubmed">12401537</ArticleId><ArticleId IdType="doi">10.1016/S0002-9343(02)01223-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Caforio ALP, Adler Y, Agostini C, Allanore Y, Anastasakis A, Arad M, B&#xf6;hm M, Charron P, Elliott PM, Eriksson U et al (2017) Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J 38:2649&#x2013;2662</Citation><ArticleIdList><ArticleId IdType="pubmed">28655210</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehx321</ArticleId></ArticleIdList></Reference><Reference><Citation>Borenstein DG, Fye WB, Arnett FC, Stevens MB (1978) The myocarditis of systemic lupus erythematosus: association with myositis. Ann Intern Med 89:619&#x2013;624. https://doi.org/10.7326/0003-4819-89-5-619</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-89-5-619</ArticleId><ArticleId IdType="pubmed">717930</ArticleId></ArticleIdList></Reference><Reference><Citation>Naarendorp M, Kerr LD, Khan AS, Ornstein MH (1999) Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: report of 6 cases. J Rheumatol 26:2257&#x2013;2260</Citation><ArticleIdList><ArticleId IdType="pubmed">10529151</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan YK, Li EK, Tam LS, Chow LTC, Ng HK (2003) Intravenous cyclophosphamide improves cardiac dysfunction in lupus myocarditis. Scand J Rheumatol 32:306&#x2013;308</Citation><ArticleIdList><ArticleId IdType="pubmed">14690145</ArticleId><ArticleId IdType="doi">10.1080/03009740310003956</ArticleId></ArticleIdList></Reference><Reference><Citation>Micheloud D, Calder&#xf3;n M, Caparrros M, D&#x2019;Cruz DP (2007) Intravenous immunoglobulin therapy in severe lupus myocarditis: good outcome in three patients. Ann Rheum Dis 66:986&#x2013;987</Citation><ArticleIdList><ArticleId IdType="pubmed">17576788</ArticleId><ArticleId IdType="pmc">1955109</ArticleId><ArticleId IdType="doi">10.1136/ard.2006.058784</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherer Y, Levy Y, Shoenfeld Y (1999) Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 18:238&#x2013;240</Citation><ArticleIdList><ArticleId IdType="pubmed">11206350</ArticleId><ArticleId IdType="doi">10.1007/s100670050091</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottenberg J-E, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Bouillet L, Dougados M et al (2005) Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis 64:913&#x2013;920</Citation><ArticleIdList><ArticleId IdType="pubmed">15550531</ArticleId><ArticleId IdType="doi">10.1136/ard.2004.029694</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohanty B, Sunder A (2020) Lupus myocarditis&#x2014;a rare case. J Fam Med Prim Care 9:4441&#x2013;4443</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_716_20</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier FMP, Frommer KW, Dinser R, Walker UA, Czirjak L, Denton CP, Allanore Y, Distler O, Riemekasten G, Valentini G et al (2012) Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research Group database. Ann Rheum Dis 71:1355&#x2013;1360</Citation><ArticleIdList><ArticleId IdType="pubmed">22615460</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2011-200742</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutolo M, Sulli A, Pizzorni C, Paolino S, Smith V (2016) Systemic sclerosis: markers and targeted treatments. Acta Reumatol Port 41:18&#x2013;25</Citation><ArticleIdList><ArticleId IdType="pubmed">27115104</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, Bullo A, Cazzato M, Tirri E, Storino F et al (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 81:139&#x2013;153</Citation><ArticleIdList><ArticleId IdType="pubmed">11889413</ArticleId><ArticleId IdType="doi">10.1097/00005792-200203000-00004</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanthuyne M, Smith V, De Langhe E, Van Praet J, Arat S, Depresseux G, Westhovens R, Blockmans D, Badot V, Cogan E et al (2012) The Belgian Systemic Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile. J Rheumatol 39:2127&#x2013;2133</Citation><ArticleIdList><ArticleId IdType="pubmed">22984273</ArticleId><ArticleId IdType="doi">10.3899/jrheum.120283</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyndall AJ, Bannert B, Vonk M, Air&#xf2; P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, M&#xfc;ller-Ladner U, Distler O et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69:1809&#x2013;1815</Citation><ArticleIdList><ArticleId IdType="pubmed">20551155</ArticleId><ArticleId IdType="doi">10.1136/ard.2009.114264</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandecasteele EH, De Pauw M, Brusselle G, Decuman S, Piette Y, De Keyser F, Smith V (2016) The heart and pulmonary arterial hypertension in systemic sclerosis. Acta Clin Belg 71:1&#x2013;18</Citation><ArticleIdList><ArticleId IdType="pubmed">27075793</ArticleId><ArticleId IdType="doi">10.1080/17843286.2015.1108538</ArticleId></ArticleIdList></Reference><Reference><Citation>Janosik DL, Osborn TG, Moore TL, Shah DG, Kenney RG, Zuckner J (1989) Heart disease in systemic sclerosis. Semin Arthritis Rheum 19:191&#x2013;200</Citation><ArticleIdList><ArticleId IdType="pubmed">2690346</ArticleId><ArticleId IdType="doi">10.1016/0049-0172(89)90032-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambova SC (2014) Manifestations in systemic sclerosis. World J Cardiol 6:993&#x2013;1005</Citation><ArticleIdList><ArticleId IdType="pubmed">25276300</ArticleId><ArticleId IdType="pmc">4176808</ArticleId><ArticleId IdType="doi">10.4330/wjc.v6.i9.993</ArticleId></ArticleIdList></Reference><Reference><Citation>Allanore Y, Avouac J, Kahan A (2008) Systemic sclerosis: an update in 2008. Jt Bone Spine 75:650&#x2013;655</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2008.07.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri C, Giuggioli D, Sebastiani M, Colaci M, Emdin M (2005) Heart involvement and systemic sclerosis. Lupus 14:702&#x2013;707</Citation><ArticleIdList><ArticleId IdType="pubmed">16218471</ArticleId><ArticleId IdType="doi">10.1191/0961203305lu2204oa</ArticleId></ArticleIdList></Reference><Reference><Citation>Pussadhamma B, Tipparot T, Chaosuwannakit N, Mahakkanukrauh A, Suwannaroj S, Nanagara R, Foocharoen C (2020) Clinical outcomes of myocarditis after moderate-dose steroid therapy in systemic sclerosis: a pilot study. Int J Rheumatol. https://doi.org/10.1155/2020/8884442</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/8884442</ArticleId><ArticleId IdType="pubmed">33414828</ArticleId><ArticleId IdType="pmc">7769651</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, B&#xf6;hm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in Collaboration with the Hear. Eur J Heart Fail 14:803&#x2013;869</Citation><ArticleIdList><ArticleId IdType="pubmed">22828712</ArticleId><ArticleId IdType="doi">10.1093/eurjhf/hfs105</ArticleId></ArticleIdList></Reference><Reference><Citation>Follansbee WP, Curtiss EI, Medsger TAJ, Steen VD, Uretsky BF, Owens GR, Rodnan GP (1984) Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med 310:142&#x2013;148</Citation><ArticleIdList><ArticleId IdType="pubmed">6690931</ArticleId><ArticleId IdType="doi">10.1056/NEJM198401193100302</ArticleId></ArticleIdList></Reference><Reference><Citation>Follansbee WP, Curtiss EI, Medsger TAJ, Owens GR, Steen VD, Rodnan GP (1984) Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. exercise radionuclide evaluation and comparison with diffuse scleroderma. Am J Med 77:489&#x2013;496</Citation><ArticleIdList><ArticleId IdType="pubmed">6475990</ArticleId><ArticleId IdType="doi">10.1016/0002-9343(84)90110-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Deswal A, Follansbee WP (1996) Cardiac involvement in scleroderma. Rheum Dis Clin North Am 22:841&#x2013;860</Citation><ArticleIdList><ArticleId IdType="pubmed">8923599</ArticleId><ArticleId IdType="doi">10.1016/S0889-857X(05)70304-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieroni M, De Santis M, Zizzo G, Bosello S, Smaldone C, Campioni M, De Luca G, Laria A, Meduri A, Bellocci F et al (2014) Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression. Semin Arthritis Rheum 43:526&#x2013;535</Citation><ArticleIdList><ArticleId IdType="pubmed">23932313</ArticleId><ArticleId IdType="doi">10.1016/j.semarthrit.2013.07.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel RJ, O&#x2019;Connor B, Mena I, Criley JM (1984) Left ventricular function at rest and during Raynaud&#x2019;s phenomenon in patients with scleroderma. Am Heart J 108:1469&#x2013;1476</Citation><ArticleIdList><ArticleId IdType="pubmed">6507243</ArticleId><ArticleId IdType="doi">10.1016/0002-8703(84)90694-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Allanore Y, Meune C, Vignaux O, Weber S, Legmann P, Kahan A (2006) Bosentan increases myocardial perfusion and function in systemic sclerosis: a magnetic resonance imaging and tissue-Doppler echography study. J Rheumatol 33:2464&#x2013;2469</Citation><ArticleIdList><ArticleId IdType="pubmed">17080515</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakubaszek M, Kwiatkowska B, Ma&#x15b;li&#x144;ska M (2015) Polymyositis and dermatomyositis as a risk of developing cancer. Reumatologia 53:101&#x2013;105</Citation><ArticleIdList><ArticleId IdType="pubmed">27407235</ArticleId><ArticleId IdType="pmc">4847280</ArticleId><ArticleId IdType="doi">10.5114/reum.2015.51510</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Wang G, Ma L, Zu N (2012) Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin Cardiol 35:686&#x2013;691</Citation><ArticleIdList><ArticleId IdType="pubmed">22847365</ArticleId></ArticleIdList></Reference><Reference><Citation>Dank&#xf3; K, Ponyi A, Constantin T, Borgulya G, Szegedi G (2004) Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine (Baltimore) 83:35&#x2013;42</Citation><ArticleIdList><ArticleId IdType="pubmed">14747766</ArticleId><ArticleId IdType="doi">10.1097/01.md.0000109755.65914.5e</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiopu E, Phillips K, MacDonald PM, Crofford LJ, Somers EC (2012) Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine. Arthritis Res Ther 14:R22</Citation><ArticleIdList><ArticleId IdType="pubmed">22284862</ArticleId><ArticleId IdType="pmc">3392815</ArticleId><ArticleId IdType="doi">10.1186/ar3704</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazzani C, Cavazzana I, Ceribelli A, Vizzardi E, Dei Cas L, Franceschini F (2010) Cardiological features in idiopathic inflammatory myopathies. J Cardiovasc Med (Hagerstown) 11:906&#x2013;911</Citation><ArticleIdList><ArticleId IdType="pubmed">20625308</ArticleId><ArticleId IdType="doi">10.2459/JCM.0b013e32833cdca8</ArticleId></ArticleIdList></Reference><Reference><Citation>Haupt HM, Hutchins GM (1982) The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients. Am J Cardiol 50:998&#x2013;1006</Citation><ArticleIdList><ArticleId IdType="pubmed">7137049</ArticleId><ArticleId IdType="doi">10.1016/0002-9149(82)90408-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Denbow CE, Lie JT, Tancredi RG, Bunch TW (1979) Cardiac involvement in polymyositis: a clinicopathologic study of 20 autopsied patients. Arthritis Rheum 22:1088&#x2013;1092</Citation><ArticleIdList><ArticleId IdType="pubmed">486220</ArticleId><ArticleId IdType="doi">10.1002/art.1780221007</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg IE (2006) The heart in dermatomyositis and polymyositis. Rheumatology (Oxford) 45:iv18&#x2013;iv21</Citation><ArticleIdList><ArticleId IdType="pubmed">16980718</ArticleId><ArticleId IdType="doi">10.1093/rheumatology/kel311</ArticleId></ArticleIdList></Reference><Reference><Citation>Lie JT (1995) Cardiac manifestations in polymyositis/dermatomyositis: how to get to heart of the matter. J Rheumatol 22:809&#x2013;811</Citation><ArticleIdList><ArticleId IdType="pubmed">8587065</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor AJ, Wortham DC, Burge JR, Rogan KM (1993) The heart in polymyositis: a prospective evaluation of 26 patients. Clin Cardiol 16:802&#x2013;808</Citation><ArticleIdList><ArticleId IdType="pubmed">8269658</ArticleId><ArticleId IdType="doi">10.1002/clc.4960161110</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;ter A, Balogh &#xc1;, Szil&#xe1;gyi S, Faludi R, Nagy-Vincze M, &#xc9;des I, Dank&#xf3; K (2015) Echocardiographic abnormalities in new-onset polymyositis/dermatomyositis. J Rheumatol 42:272&#x2013;281</Citation><ArticleIdList><ArticleId IdType="pubmed">25433528</ArticleId><ArticleId IdType="doi">10.3899/jrheum.140626</ArticleId></ArticleIdList></Reference><Reference><Citation>Erlacher P, Lercher A, Falkensammer J, Nassonov EL, Samsonov MI, Shtutman VZ, Puschendorf B, Mair J (2001) Cardiac troponin and beta-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis. Clin Chim Acta 306:27&#x2013;33</Citation><ArticleIdList><ArticleId IdType="pubmed">11282091</ArticleId><ArticleId IdType="doi">10.1016/S0009-8981(01)00392-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodor GS, Porterfield D, Voss EM, Smith S, Apple FS (1995) Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem 41:1710&#x2013;1715</Citation><ArticleIdList><ArticleId IdType="pubmed">7497610</ArticleId><ArticleId IdType="doi">10.1093/clinchem/41.12.1710</ArticleId></ArticleIdList></Reference><Reference><Citation>Hengstman GJD, ter Laak HJ, Vree Egberts WTM, Lundberg IE, Moutsopoulos HM, Vencovsky J, Doria A, Mosca M, van Venrooij WJ, van Engelen BGM (2006) Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis 65:1635&#x2013;1638</Citation><ArticleIdList><ArticleId IdType="pubmed">16679430</ArticleId><ArticleId IdType="pmc">1798474</ArticleId><ArticleId IdType="doi">10.1136/ard.2006.052191</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwer R, Hengstman GJ, Vree Egberts W, Ehrfeld H, Bozic B, Ghirardello A, Gr&#xf8;ndal G, Hietarinta M, Isenberg D, Kalden JR et al (2001) Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 60:116&#x2013;123</Citation><ArticleIdList><ArticleId IdType="pubmed">11156543</ArticleId><ArticleId IdType="pmc">1753477</ArticleId><ArticleId IdType="doi">10.1136/ard.60.2.116</ArticleId></ArticleIdList></Reference><Reference><Citation>Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70:360&#x2013;374</Citation><ArticleIdList><ArticleId IdType="pubmed">1659647</ArticleId><ArticleId IdType="doi">10.1097/00005792-199111000-00002</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada Y, Takakuwa Y, Ooka S, Ogawa Y, Kawahata K, Kobayashi Y, Yamaguchi K, Akashi Y (2021) Usefulness of 123I-BMIPP and 201TlCl nuclide scintigraphy in evaluation of myocarditis in patients with polymyositis or dermatomyositis. Medicine (Baltimore) 100:e27173</Citation><ArticleIdList><ArticleId IdType="pubmed">34516513</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000027173</ArticleId></ArticleIdList></Reference><Reference><Citation>Shigematsu T, Okayama H, Hiasa G, Kazatani Y (2016) (18)F-Fluorodeoxyglucose positron emission tomography for the diagnosis of myocarditis associated with polymyositis. Circ J 81:121&#x2013;122</Citation><ArticleIdList><ArticleId IdType="pubmed">27733736</ArticleId><ArticleId IdType="doi">10.1253/circj.CJ-16-0811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohata S, Shimada T, Shimizu H, Murakami Y, Matsuno Y (2002) Myocarditis associated with polymyositis diagnosed by gadolinium-DTPA enhanced magnetic resonance imaging. J Rheumatol 29:861&#x2013;862</Citation><ArticleIdList><ArticleId IdType="pubmed">11950039</ArticleId></ArticleIdList></Reference><Reference><Citation>Allanore Y, Vignaux O, Arnaud L, Pu&#xe9;chal X, Pavy S, Duboc D, Legmann P, Kahan A (2006) Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Ann Rheum Dis 65:249&#x2013;252</Citation><ArticleIdList><ArticleId IdType="pubmed">16410529</ArticleId><ArticleId IdType="pmc">1798005</ArticleId><ArticleId IdType="doi">10.1136/ard.2005.038679</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbasso Helmers S, Dastmalchi M, Alexanderson H, Nennesmo I, Esbj&#xf6;rnsson M, Lindvall B, Lundberg IE (2007) Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies. Ann Rheum Dis 66:1276&#x2013;1283</Citation><ArticleIdList><ArticleId IdType="pubmed">17277004</ArticleId><ArticleId IdType="doi">10.1136/ard.2006.058644</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheston HJ, Akhoon C, Dutta Roy S, Reynolds P (2022) Managing myocarditis in a patient with newly diagnosed dermatomyositis. BMJ Case Rep 15:e246989</Citation><ArticleIdList><ArticleId IdType="pubmed">35256366</ArticleId><ArticleId IdType="doi">10.1136/bcr-2021-246989</ArticleId></ArticleIdList></Reference><Reference><Citation>Touma Z, Arayssi T, Kibbi L, Masri AF (2008) Successful treatment of cardiac involvement in dermatomyositis with rituximab. Jt Bone Spine 75:334&#x2013;337</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2007.05.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Afzal A, Higgins RS, Philbin EF (1999) Heart transplant for dilated cardiomyopathy associated with polymyositis. Heart 82:e4</Citation><ArticleIdList><ArticleId IdType="pubmed">10490578</ArticleId><ArticleId IdType="pmc">1760297</ArticleId><ArticleId IdType="doi">10.1136/hrt.82.4.e4</ArticleId></ArticleIdList></Reference><Reference><Citation>Ntusi NAB, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD, Wordsworth PB, Neubauer S, Karamitsos TD (2015) Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping. JACC Cardiovasc Imaging 8:526&#x2013;536</Citation><ArticleIdList><ArticleId IdType="pubmed">25890584</ArticleId><ArticleId IdType="doi">10.1016/j.jcmg.2014.12.025</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigal LH, Friedman HD (1989) Rheumatoid pancarditis in a patient with well controlled rheumatoid arthritis. J Rheumatol 16:368&#x2013;373</Citation><ArticleIdList><ArticleId IdType="pubmed">2724254</ArticleId></ArticleIdList></Reference><Reference><Citation>Howlett JG, McKelvie RS, Arnold JMO, Costigan J, Dorian P, Ducharme A, Estrella-Holder E, Ezekowitz JA, Giannetti N, Haddad H et al (2009) Canadian Cardiovascular Society consensus conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol 25:85&#x2013;105</Citation><ArticleIdList><ArticleId IdType="pubmed">19214293</ArticleId><ArticleId IdType="pmc">2691911</ArticleId><ArticleId IdType="doi">10.1016/S0828-282X(09)70477-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Amigues I, Tugcu A, Russo C, Giles JT, Morgenstein R, Zartoshti A, Schulze C, Flores R, Bokhari S, Bathon JM (2019) Myocardial inflammation, measured using 18-fluorodeoxyglucose positron emission tomography with computed tomography, is associated with disease activity in rheumatoid arthritis. Arthritis Rheumatol (Hoboken, N.J.) 71:496&#x2013;506</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40771</ArticleId></ArticleIdList></Reference><Reference><Citation>Slack JD, Waller B (1986) Acute congestive heart failure due to the arteritis of rheumatoid arthritis: early diagnosis by endomyocardial biopsy: a case report. Angiology 37:477&#x2013;482</Citation><ArticleIdList><ArticleId IdType="pubmed">3729074</ArticleId><ArticleId IdType="doi">10.1177/000331978603700609</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon HJ, Cot&#xe9; TR, Cuffe MS, Kramer JM, Braun MM (2003) Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med 138:807&#x2013;811</Citation><ArticleIdList><ArticleId IdType="pubmed">12755552</ArticleId><ArticleId IdType="doi">10.7326/0003-4819-138-10-200305200-00008</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang M, Bao L, Xiong N, Jin B, Ni H, Zhang J, Zou H, Luo X, Li J (2015) Cardiac arrhythmias as the initial manifestation of adult primary Sj&#xf6;gren&#x2019;s syndrome: a case report and literature review. Int J Rheum Dis 18:800&#x2013;806</Citation><ArticleIdList><ArticleId IdType="pubmed">26171561</ArticleId><ArticleId IdType="doi">10.1111/1756-185X.12616</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue H, Kinoshita K, Sugiyama M, Funauchi M, Hanagama M, Nata M (2008) Sudden death from ischaemic heart disease in a female patient with Sj&#xf6;gren syndrome: a case report. Med Sci Law 48:261&#x2013;265</Citation><ArticleIdList><ArticleId IdType="pubmed">18754216</ArticleId><ArticleId IdType="doi">10.1258/rsmmsl.48.3.261</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin MD, Zoet-Nugteren SK, Markusse HM (1999) Myocarditis and primary Sj&#xf6;gren&#x2019;s syndrome. Lancet (London, England) 354:128&#x2013;129</Citation><ArticleIdList><ArticleId IdType="pubmed">10408493</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(99)02251-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe T, Takahashi Y, Hirabayashi K, Tomaru U, Machida M (2019) Acute fulminant myocarditis in a patient with primary Sj&#xf6;gren&#x2019;s syndrome. Scand J Rheumatol 48:164&#x2013;165</Citation><ArticleIdList><ArticleId IdType="pubmed">30516409</ArticleId><ArticleId IdType="doi">10.1080/03009742.2018.1514068</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR (1972) Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148&#x2013;159</Citation><ArticleIdList><ArticleId IdType="pubmed">4621694</ArticleId><ArticleId IdType="doi">10.1016/0002-9343(72)90064-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves MR, Isenberg DA (2020) &#x201c;Mixed connective tissue disease&#x201d;: a condition in search of an identity. Clin Exp Med 20:159&#x2013;166</Citation><ArticleIdList><ArticleId IdType="pubmed">32130548</ArticleId><ArticleId IdType="pmc">7181542</ArticleId><ArticleId IdType="doi">10.1007/s10238-020-00606-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappelli S, Bellando Randone S, Martinovi&#x107; D et al (2012) &#x2018;To be or not to be&#x2019;, ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum 41:589&#x2013;598</Citation><ArticleIdList><ArticleId IdType="pubmed">21959290</ArticleId><ArticleId IdType="doi">10.1016/j.semarthrit.2011.07.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungprasert P, Wannarong T, Panichsillapakit T, Cheungpasitporn W, Thongprayoon C, Ahmed S, Raddatz DA (2014) Cardiac involvement in mixed connective tissue disease: a systematic review. Int J Cardiol 171:326&#x2013;330</Citation><ArticleIdList><ArticleId IdType="pubmed">24433611</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2013.12.079</ArticleId></ArticleIdList></Reference><Reference><Citation>Alpert MA, Goldberg SH, Singsen BH et al (1983) Cardiovascular manifestations of mixed connective tissue disease in adults. Circulation 68:1182&#x2013;1193</Citation><ArticleIdList><ArticleId IdType="pubmed">6640871</ArticleId><ArticleId IdType="doi">10.1161/01.CIR.68.6.1182</ArticleId></ArticleIdList></Reference><Reference><Citation>Oetgen WJ, Mutter ML, Lawless OJ et al (1983) Cardiac abnormalities in mixed connective tissue disease. Chest 83:185&#x2013;188</Citation><ArticleIdList><ArticleId IdType="pubmed">6822098</ArticleId><ArticleId IdType="doi">10.1378/chest.83.2.185</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung WH, Wong KL, Lau CP et al (1990) Echocardiographic identification of mitral valvular abnormalities in patients with mixed connective tissue disease. J Rheumatol 17:485&#x2013;488</Citation><ArticleIdList><ArticleId IdType="pubmed">2348428</ArticleId></ArticleIdList></Reference><Reference><Citation>Burdt MA, Hoffman RW, Deutscher SL et al (1999) Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 42:899&#x2013;909</Citation><ArticleIdList><ArticleId IdType="pubmed">10323445</ArticleId><ArticleId IdType="doi">10.1002/1529-0131(199905)42:5&lt;899::AID-ANR8&gt;3.0.CO;2-L</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajas A, Szodoray P, Nakken B et al (2013) Clinical course prognosis and causes of death in mixed connective tissue disease. J Rheumatol 40:1134&#x2013;1142</Citation><ArticleIdList><ArticleId IdType="pubmed">23637328</ArticleId><ArticleId IdType="doi">10.3899/jrheum.121272</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebollar-Gonz&#xe1;lez V, Torre-Delgadillo A, Orea-Tejeda A et al (2001) Cardiac conduction disturbances in mixed connective tissue disease. Rev Investig Clin 53:330&#x2013;334</Citation></Reference><Reference><Citation>Whitlow PL, Gilliam JN, Chubick A, Ziff M (1980) Myocarditis in mixed connective tissue disease. Association of myocarditis with antibody to nuclear ribonucleoprotein. Arthritis Rheum 23:808&#x2013;815</Citation><ArticleIdList><ArticleId IdType="pubmed">7406932</ArticleId><ArticleId IdType="doi">10.1002/art.1780230706</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>